跳转至内容
Merck
CN

SML1621

Sigma-Aldrich

OSMI-1

≥98% (HPLC), powder, OGT inhibitor

别名:

(αR)-α-[[(1,2-二氢-2-氧代-6-喹啉基)磺酰基]氨基]-N-(2-呋喃基甲基)-2-甲氧基-N-(2-噻吩甲基)苯乙酰胺, OSMI 1

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C28H25N3O6S2
分子量:
563.64
UNSPSC代码:
51111800
PubChem化学物质编号:
NACRES:
NA.77

产品名称

OSMI-1, ≥98% (HPLC)

质量水平

方案

≥98% (HPLC)

表单

powder

颜色

white to beige

溶解性

DMSO: 20 mg/mL, clear

储存温度

2-8°C

SMILES字符串

O=C(N1)C=CC2=C1C=CC(S(N[C@H](C3=C(OC)C=CC=C3)C(N(CC4=CC=CS4)CC5=CC=CO5)=O)(=O)=O)=C2

InChI

1S/C28H25N3O6S2/c1-36-25-9-3-2-8-23(25)27(28(33)31(17-20-6-4-14-37-20)18-21-7-5-15-38-21)30-39(34,35)22-11-12-24-19(16-22)10-13-26(32)29-24/h2-16,27,30H,17-18H2,1H3,(H,29,32)/t27-/m1/s1

InChI key

IYIGLWQQAMROOF-HHHXNRCGSA-N

应用

OSMI-1(OGT的小分子抑制剂)已可用于邻位连接分析、Sox2(SRY(性别决定区Y)-Box 2)双荧光素酶报告基因检测、Sox2 ELISA(酶联免疫吸附测定)以及其他 体内 方法 ,以研究 O-连接的β-N-乙酰氨基葡萄糖(O-GlcNAc)介导的癌症自我更新基因的调控。它还被用于研究由O-GlcNAc转移酶介导的Hippo途径调节。

生化/生理作用

OSMI-1是一种细胞渗透性OGT(O-GlcNAc转移酶)抑制剂。
在翻译后修饰过程中,OGT可催化 N-乙酰葡糖胺部分与多种蛋白质的连接。抑制OGT活性,可能会降低病毒在感染过程中的复制率,如单纯疱疹病毒性疾病。

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

O-GlcNAc modification of oncogenic transcription factor Sox2 promotes protein stability and regulates self-renewal in pancreatic cancer.
Sharma N, et al.
bioRxiv, 345223-345223 (2018)
O-GlcNAc transferase inhibitors: current tools and future challenges.
Trapannone R, et al.
Biochemical Society Transactions, 44(1), 88-93 (2016)
Regulation of the hippo-YAP pathway by glucose sensor O-GlcNAcylation.
Peng C, et al.
Molecular Cell, 68(3), 591-604 (2018)
Hye-Yeon Kim et al.
Bioprocess and biosystems engineering, 43(5), 863-875 (2020-01-26)
O-Glycosylation occurs in recombinant proteins produced by CHO cells, but this phenomenon has not been studied extensively. Here, we report that rituximab is an O-linked N-acetyl-glucosaminylated (O-GlcNAcylated) protein and the production of rituximab is increased by thiamet G, an inhibitor
Nikita S Sharma et al.
Theranostics, 9(12), 3410-3424 (2019-07-10)
Pancreatic adenocarcinoma (PDAC) claims more than 90% of the patients diagnosed with the disease owing to its aggressive biology that is manifested by high rate of tumor recurrence. Aberrant upregulation in the transcriptional activity of proteins involved in self-renewal like

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门